We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




CT Angiography Shows Gender Differences in Heart Attack Risk

By HospiMedica International staff writers
Posted on 19 Dec 2011
Recent research on coronary computed tomography angiography (CTA), a noninvasive imaging modality used to evaluate the coronary arteries for blockages, reveals different risk scenarios for men and women.

The findings were presented at the scientific assembly and annual meeting of the Radiological Society of North America (RSNA), held November 27-December 2, 2011, in Chicago (IL, USA). More...


Coronary artery disease (CAD) is a narrowing of the blood vessels that supply blood and oxygen to the heart. It is caused by a build-up of fat and other substances that form plaque on vessel walls. According to the US Centers for Disease Control and Prevention (Atlanta, GA, USA), heart disease is the leading cause of death for both men and women in the United States.

Researchers from the Medical University of South Carolina (Charleston, USA; www.musc.edu) analyzed the results of coronary CTA on 480 patients, mean age 55, with acute chest pain. Approximately 65% of the patients were women, and 35% were men. The probability of acute coronary syndrome was ruled out for each of the patients.

Utilizing coronary CTA, the researchers were able to determine the number of vessel segments with plaque, the severity of the blockage and the composition of the plaque. “The latest CT scanners are able to produce images that allow us to determine whether the plaque is calcified, noncalcified, or mixed,” said John W. Nance Jr., MD, currently a radiology resident at Johns Hopkins Hospital (Baltimore, MD, USA).

By comparing the coronary CTA results with outcome data over a 12.8-month follow-up period, the researchers were able to correlate the extent, severity, and type of plaque build-up with the occurrence of major adverse cardiac events, such as a heart attack or coronary bypass surgery. The statistical analysis tested all plaques combined (calcified, noncalcified and mixed) and each individual plaque type separately. “We found that the risks for cardiovascular events associated with plaque were significantly different between women and men,” Dr. Nance said.

Within the follow-up period, 70 of the patients experienced major adverse cardiac events, such as death, heart attack, unstable angina, or revascularization. In total, 87 major adverse cardiac events occurred among the patients during the follow-up period. When outcome data were correlated with the CTA combined plaque findings, the results indicated that women with a large amount of plaque accumulation and extensive atherosclerosis are at significantly greater cardiovascular risk than men.

Specifically, the risk for major adverse cardiac events was considerably higher in women than in men when extensive plaque of any type was present or when more than four artery segments were narrowed. “This research tells us that extensive coronary plaque is more worrisome in women than the equivalent amount in men,” Dr. Nance said.

However, when studying risk factors tied to the presence of individual types of plaque, the risk for major adverse cardiac events was greater in men, compared to women, when their artery segments contained noncalcified plaque.

Dr. Nance reported that the new data suggested that the atherosclerotic process is not necessarily linear and that more research is needed to better understand the disease. “Our research confirms that coronary CTA provides excellent prognostic information that helps identify risk, but there are gender differences that need to be considered.”

Related Links:
Medical University of South Carolina




Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.